Valneva SE (VALN) Net Income (2021 - 2026)

Valneva SE (VALN) posted quarterly Net Income of -$34.6 million for Q1 2026, down 384.17% year-on-year from $12.2 million in Q1 2025, and up 39.25% on a QoQ basis from -$57.0 million in Q4 2025.

Valneva SE (VALN) Net Income (2021 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Net Income for 6 consecutive years, with -$34.6 million the latest figure, recorded in Q1 2026.

  • Quarterly Net Income fell 384.17% year-over-year to -$34.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$158.6 million (down 79.83% YoY) and the FY2025 annual result came in at -$131.1 million, down 837.81% from the prior year.
  • Net Income improved to -$34.6 million in Q1 2026 per VALN's latest filing, from -$57.0 million in the prior quarter.
  • Over the last five years, Net Income for VALN reached as high as $307.9 million in Q3 2022 and fell as low as -$275.8 million in Q4 2022.
  • A 5-year average of -$26.4 million and a median of -$32.9 million in 2023 frame the typical range for Net Income.
  • Annual changes were most pronounced in 2024 — Net Income surged 225.07% — and 2025, when it slumped 426.23%.
  • Year by year, Net Income stood at -$275.8 million in 2022, then surged by 87.64% to -$34.1 million in 2023, then slipped by 23.69% to -$42.2 million in 2024, then sank by 35.17% to -$57.0 million in 2025, then soared by 39.25% to -$34.6 million in 2026.
  • According to Business Quant data, Net Income over the past three periods registered -$34.6 million, -$57.0 million, and -$53.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -37.09 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 227.36 Mn
4 NuCana 279.75 Bn 279.75 Bn - -3.31 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 727.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -26.94 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 362.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -453.82 Mn
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn -34.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -34.62 Mn
Dec 31, 2025 -56.99 Mn
Sep 30, 2025 -53.28 Mn
Jun 30, 2025 -13.69 Mn
Mar 31, 2025 -7.15 Mn
Dec 31, 2024 -42.16 Mn
Sep 30, 2024 -10.13 Mn
Jun 30, 2024 -28.75 Mn
Mar 31, 2024 67.06 Mn
Dec 31, 2023 -34.08 Mn
Sep 30, 2023 -32.86 Mn
Jun 30, 2023 -60.51 Mn
Mar 31, 2023 20.63 Mn
Dec 31, 2022 -275.79 Mn
Sep 30, 2022 307.89 Mn
Jun 30, 2022 -165.52 Mn
Mar 31, 2022 -29.63 Mn
Dec 31, 2021 -363.41 Mn
Sep 30, 2021 181.54 Mn
Jun 30, 2021 66.79 Mn